{
    "organizations": [],
    "uuid": "2e3734adc84d07b7be2a1725801424c69d5f6514",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ajanta-pharma-says-no-form-483-iss/brief-ajanta-pharma-says-no-form-483-issued-by-usfda-to-facility-at-dahej-idUSFWN1PZ0W3",
    "ord_in_thread": 0,
    "title": "BRIEF-Ajanta Pharma Says No Form 483 Issued By USFDA To Facility At Dahej",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 9 (Reuters) - Ajanta Pharma Ltd:\n* SAYS FORMULATION FACILITY AT DAHEJ WAS INSPECTED BY US FDA FROM 5TH TO 9TH FEBRUARY\n* SAYS NO FORM 483 WAS ISSUED TO CO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-09T20:02:00.000+02:00",
    "crawled": "2018-02-10T14:04:04.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "ajanta",
        "pharma",
        "ltd",
        "say",
        "formulation",
        "facility",
        "dahej",
        "inspected",
        "u",
        "fda",
        "5th",
        "9th",
        "february",
        "say",
        "form",
        "issued",
        "co",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}